These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 15979535)
1. Can protonated beta-blockers interact with biomembranes stronger than neutral isolipophilic compounds? A chromatographic study on three different phospholipid stationary phases (IAM-HPLC). Barbato F; di Martino G; Grumetto L; La Rotonda MI Eur J Pharm Sci; 2005; 25(4-5):379-86. PubMed ID: 15979535 [TBL] [Abstract][Full Text] [Related]
2. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents. Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545 [TBL] [Abstract][Full Text] [Related]
3. Prediction of drug-membrane interactions by IAM-HPLC: effects of different phospholipid stationary phases on the partition of bases. Barbato F; di Martino G; Grumetto L; La Rotonda MI Eur J Pharm Sci; 2004 Jul; 22(4):261-9. PubMed ID: 15196582 [TBL] [Abstract][Full Text] [Related]
4. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data. Grumetto L; Carpentiero C; Barbato F Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648 [TBL] [Abstract][Full Text] [Related]
5. Capillary electrochromatography as a new tool to assess drug affinity for membrane phospholipids. Barbato F; Grumetto L; Carpentiero C; Rocco A; Fanali S J Pharm Biomed Anal; 2011 Apr; 54(5):893-9. PubMed ID: 21168987 [TBL] [Abstract][Full Text] [Related]
6. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data. Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809 [TBL] [Abstract][Full Text] [Related]
7. Electrostatic interactions and ionization effect in immobilized artificial membrane retention. A comparative study with octanol-water partitioning. Vrakas D; Giaginis C; Tsantili-Kakoulidou A J Chromatogr A; 2008 Apr; 1187(1-2):67-78. PubMed ID: 18291408 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions. Caldwell GW; Masucci JA; Evangelisto M; White R J Chromatogr A; 1998 Mar; 800(2):161-9. PubMed ID: 9561760 [TBL] [Abstract][Full Text] [Related]
9. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs. Kotecha J; Shah S; Rathod I; Subbaiah G Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172 [TBL] [Abstract][Full Text] [Related]
10. Prediction and mechanism elucidation of analyte retention on phospholipid stationary phases (IAM-HPLC) by in silico calculated physico-chemical descriptors. Russo G; Grumetto L; Barbato F; Vistoli G; Pedretti A Eur J Pharm Sci; 2017 Mar; 99():173-184. PubMed ID: 27919703 [TBL] [Abstract][Full Text] [Related]
11. Enantioselective retention of beta-blocking agents on human serum albumin and alpha 1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity. Barbato F; Carpentiero C; Grumetto L; La Rotonda MI Eur J Pharm Sci; 2009 Dec; 38(5):472-8. PubMed ID: 19778607 [TBL] [Abstract][Full Text] [Related]
12. Immobilized Artificial Membrane HPLC Derived Parameters vs PAMPA-BBB Data in Estimating in Situ Measured Blood-Brain Barrier Permeation of Drugs. Grumetto L; Russo G; Barbato F Mol Pharm; 2016 Aug; 13(8):2808-16. PubMed ID: 27377191 [TBL] [Abstract][Full Text] [Related]
13. Insight into the retention mechanism on immobilized artificial membrane chromatography using two stationary phases. Tsopelas F; Malaki N; Vallianatou T; Chrysanthakopoulos M; Vrakas D; Ochsenkühn-Petropoulou M; Tsantili-Kakoulidou A J Chromatogr A; 2015 May; 1396():25-33. PubMed ID: 25911385 [TBL] [Abstract][Full Text] [Related]
14. The effect of stationary phase on lipophilicity determination of beta-blockers using reverse-phase chromatographic systems. Welerowicz T; Buszewski B Biomed Chromatogr; 2005 Dec; 19(10):725-36. PubMed ID: 15856476 [TBL] [Abstract][Full Text] [Related]
15. Indexes of polar interactions between ionizable drugs and membrane phospholipids measured by IAM-HPLC: their relationships with data of Blood-Brain Barrier passage. Grumetto L; Russo G; Barbato F Eur J Pharm Sci; 2014 Dec; 65():139-46. PubMed ID: 25262853 [TBL] [Abstract][Full Text] [Related]
16. Investigation of lipophilicity of anticancer-active thioquinoline derivatives. Bajda M; Boryczka S; Wietrzyk J; Malawska B Biomed Chromatogr; 2007 Feb; 21(2):123-31. PubMed ID: 17120300 [TBL] [Abstract][Full Text] [Related]
17. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning. Vrakas D; Giaginis C; Tsantili-Kakoulidou A J Chromatogr A; 2006 May; 1116(1-2):158-64. PubMed ID: 16595136 [TBL] [Abstract][Full Text] [Related]
18. Chromatographic estimation of drug disposition properties by means of immobilized artificial membranes (IAM) and C18 columns. Lázaro E; Ràfols C; Abraham MH; Rosés M J Med Chem; 2006 Aug; 49(16):4861-70. PubMed ID: 16884298 [TBL] [Abstract][Full Text] [Related]
19. Determination of lipophilic descriptors of antihelmintic 6,7-diaryl-pteridine derivatives useful for bioactivity predictions. Reta M; Giacomelli L; Santo M; Cattana R; Silber JJ; Ochoa C; Rodriguez M; Chana A Biomed Chromatogr; 2003 Sep; 17(6):365-72. PubMed ID: 13680846 [TBL] [Abstract][Full Text] [Related]
20. Polar interactions drug/phospholipids estimated by IAM-HPLC vs cultured cell line passage data: Their relationships and comparison of their effectiveness in predicting drug human intestinal absorption. Grumetto L; Russo G; Barbato F Int J Pharm; 2016 Mar; 500(1-2):275-90. PubMed ID: 26780120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]